Is now the time to buy these 3 beaten-up shares?

Amaysim Australia Ltd (ASX:AYS) or Primary Health Care Limited (ASX:PRY): Is now a great time to pick up these three beaten up shares?

| More on:
a woman

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

"In the short run, the market is a voting machine but in the long run, it is a weighing machine." – Benjamin Graham

This famous quote by Benjamin Graham succinctly sums up the point that markets are often wrong in the short term, but rarely wrong over the long term.

It's just the nature of the markets that emotion and sentiment will cause shares to overshoot at the high points and undershoot at the low points, but over time they will trade back towards their intrinsic value.

These short term over-reactions often present the best opportunities for investors, but they can also create value traps for unsuspecting buyers.

So with those points in mind, here are three shares that investors may be tempted to consider following significant share price declines:

Amaysim Australia Ltd (ASX: AYS) – Following a spectacular run-up post its IPO in July last year, shares of junior telco company Amaysim have failed to recover after it released a weaker-than-expected maiden interim profit result in February. The shares are now trading at $1.70 – nearly 49% down from its all time high of $3.33.

It appears investors are now sitting on the sidelines until the company releases its full year result, which will reveal whether or not it will meet its prospectus forecasts.

Although underlying earnings increased sharply in its interim results, Amaysim added just over 85,000 new subscribers by the end of 2015, down from growth of 183,000 users a year earlier. It is this slowing subscriber growth that is concerning the market and an important factor that will determine whether or not the share price can recover.

As a result, I don't think investors should rush out to buy shares in Amaysim just yet, but rather wait to re-assess the situation after the company provides a further update to the market.

Mcgrath Ltd (ASX: MEA) – The recent listing of the real estate agent has been a complete disaster for investors with the shares not once trading over their IPO price of $2.10.

The shares fell more than 30% yesterday after the company announced it would not meet its prospectus forecasts due to a material reduction in Sydney property listings, reduced foreign investment activity, and other administrative issues.

It is becoming more apparent that the IPO listing may have been timed to perfection but at the expense of new investors and while the shares appear cheap on face value, I would not be tempted to buy shares of McGrath at this point in time.

Primary Health Care Limited (ASX: PRY) – Although the shares have recently bounced significantly off their lows, investors have still seen a more than 30% decline in value from this point 12 months ago.

The company has consistently disappointed investors over the long term and is one of the few profitable healthcare companies listed on the ASX to deliver a negative return to shareholders over the past 10 years.

Its most recent poor performance highlights its reliance on government expenditure with subdued trading conditions being experienced as a result of an ongoing Government Medicare review and budget cutbacks.

High levels of debt, skinny operating margins and a valuation that is currently factoring in a potential takeover are just a few of the factors that, in my opinion, makes Primary less attractive than other companies in the healthcare sector.

Looking for fully franked dividends at a bargain price?

Just released exclusively for Motley Fool readers!

Motley Fool contributor Christopher Georges has no position in any stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

More on ⏸️ Investing

A white and black robot in the form of a human being stands in front of a green graphic holding a laptop and discussing robotics and automation ASX shares
Technology Shares

Joining the revolution: How I'd invest in ASX AI shares right now

Advances in artificial intelligence (AI) could usher in a new industrial revolution. Here’s how you can invest in it.

Read more »

Close up of baby looking puzzled
Retail Shares

What has happened to the Baby Bunting (ASX:BBN) share price this year?

It's been a volatile year so far for the Aussie nursery retailer. We take a closer look

Read more »

woman holds sign saying 'we need change' at climate change protest
ETFs

3 ASX ETFs that invest in companies fighting climate change

If you want to shift some of your investments into more ethical companies, exchange-traded funds can offer a good option

Read more »

a jewellery store attendant stands at a cabinet displaying opulent necklaces and earrings featuring diamonds and precious stones.
⏸️ Investing

The Michael Hill (ASX: MHJ) share price poised for growth

Investors will be keeping an eye on the Michael Hill International Limited (ASX: MHJ) share price today. The keen interest…

Read more »

ASX shares buy unstoppable asx share price represented by man in superman cape pointing skyward
⏸️ Investing

The Atomos (ASX:AMS) share price is up 15% in a week

The Atomos (ASX: AMS) share price has surged 15% this week. Let's look at what's ahead as the company build…

Read more »

Two people in suits arm wrestle on a black and white chess board.
Retail Shares

How does the Temple & Webster (ASX:TPW) share price stack up against Nick Scali (ASX:NCK)?

How does the Temple & Webster (ASX: TPW) share price stack up against rival furniture retailer Nick Scali Limited (ASX:…

Read more »

A medical researcher works on a bichip, indicating share price movement in ASX tech companies
Healthcare Shares

The Aroa (ASX:ARX) share price has surged 60% since its IPO

The Aroa (ASX:ARX) share price has surged 60% since the Polynovo (ASX: PNV) competitor listed on the ASX in July.…

Read more »

asx investor daydreaming about US shares
⏸️ How to Invest

How to buy US shares from Australia right now

If you have been wondering how to buy US shares from Australia to gain exposure from the highly topical market,…

Read more »